| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Century Therapeutics, Inc. | President of R&D | Common Stock | 537K | $2.76M | $5.14 | Mar 7, 2024 | By Irrevocable Spousal Trust for Rhonda L. Zuckerman |
| Century Therapeutics, Inc. | President of R&D | Common Stock | 24K | $123K | $5.14 | Mar 7, 2024 | Direct |
| Century Therapeutics, Inc. | President of R&D | Stock Option (right to buy) | 146K | Mar 7, 2024 | Direct | ||
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 32K | Apr 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Director |
| IPSC | Century Therapeutics, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 11, 2024 | President of R&D |
| IPSC | Century Therapeutics, Inc. | Apr 12, 2023 | 1 | $0 | 4 | Apr 14, 2023 | President of R&D |
| IPSC | Century Therapeutics, Inc. | Apr 12, 2023 | 0 | $0 | 3 | Apr 14, 2023 | President of R&D |
| REPL | Replimune Group, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |
| IPSC | Century Therapeutics, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | President of R&D |
| IPSC | Century Therapeutics, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | President of R&D |